Human Papillomavirus (HPV) Literature

Alberts CJ, Heard I, Canestri A, et al. Incidence and clearance of anal HPV-16 and HPV-18 infection, and their determinants, among HIV-infected men who have sex with men in France. J Infect Dis 2019 (published online Nov 22)

Balaji R, MacCosham A, Williams K, et al. Directionality of genital human papillomavirus infection transmission within heterosexual couples: a systematic review and meta-analysis. J Infect Dis 2020 (published online Jun 3)

Batmunkh T, Dalmau MT, Munkhsaikhan ME, et al. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination. Vaccine 2020 Jun 2;38(27):4316-24

Berggrund M, Gustavsson I, Aarnio R, et al. HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia. Virol J 2019 Nov 27;16:146

Braeye T, Emborg HD, Llorente-Garcia A, et al. Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries – The ADVANCE project. Vaccine 2020 (published online Mar 12)

Bukowinski AT, Hall C, Chang RN, et al. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy. Vaccine 2020 (published online Jul 22)

Chaturvedi AK, Graubard BI, Broutian T, et al. Prevalence of oral HPV infection in unvaccinated men and women in the United States, 2009-2016. (Research letter) JAMA 2019 Sep 10;322(10):977-9

Chow EPF, Danielewski JA, Murray GL, et al. Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia. Vaccine 2019 (published online Sep 11)

Chow EPF, Tabrizi SN, Fairley CK, et al. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017. Vaccine 2019 (published online Sep 24)

Cornall AM, Saville M, Pyman J, et al. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination. Vaccine 2020 (published online Jul 28)

Cotte L, Veyer D, Charreau I, et al. Prevalence and incidence of HPV infection in men having sex with men enrolled in a PrEP study: a sub-study of the ANRS IPERGAY trial. Clin Infect Dis 2020 (published online Jan 7)

Donahue JG, Kieke BA, Lewis EM, et al. Near real-time surveillance to assess the safety of the 9-valent human papillomavirus vaccine. Pediatrics 2019 (published online Nov 18)

Donken R, Dobson SRM, Marty KD, et al. Immunogenicity of 2 and 3 doses of the quadrivalent HPV vaccine up to 120 months post-vaccination; follow-up of a randomized clinical trial. Clin Infect Dis 2019 (published online Sep 6)

Fullerton ZH, Butler SS, Mahal BA, et al. Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status. Cancer 2020 (published online Jan 13)

Gerend MA, Murdock C, Grove K. An intervention for increasing HPV vaccination on a university campus. Vaccine 2019 (published online Nov 23)

Gortz M, Brewer NT, Hansen PR, et al. The contagious nature of a vaccine scare: how the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark. Vaccine 2020 (published online May 15)

Hansen PR, Schmidtblaicher M, Brewer NT. Resilience of HPV vaccine uptake in Denmark: decline and recovery. Vaccine 2020 (published online Jan 7)

Hoes J, Pasmans H, Knol MJ, et al. Persisting antibody response nine years after bivalent HPV vaccination in a cohort of Dutch women: immune response and the relation with genital HPV infections. J Infect Dis 2020 (published online Jan 9)

Inguva S, Barnard M, Ward LM, et al. Factors influencing human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid. Vaccine 2020 (published online Jan 21)

Jones JLJ, Gargano JW, Powell M, et al. Effectiveness of 1, 2 and 3 human papillomavirus vaccine doses against HPV-16/18 positive high-grade cervical lesions. Am J Epidemiol 2019 (published online Nov 4)

Kelly MK, Grundmeier RW, Stephens-Shields AJ, et al. Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: an AAP pediatric research in office settings (PROS) national primary care research network study. Vaccine 2020 Jul 14;38(33):5105-8

Kempe A, O'Leary ST, Markowitz LE, et al. HPV vaccine delivery practices by primary care physicians. Pediatrics 2019 (published online Sep 16)

Ko JS, Goldbeck CS, Baughan EB, et al. Association between human papillomavirus vaccination school-entry requirements and vaccination initiation. JAMA Pediatr 2020 (published online Jun 29)

Kuhn L, Saidu R, Boa R, et al. Clinical evaluation of modifications to a human papillomavirus assay to optimize its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. Lancet Glob Health 2020 Feb 1;8(2):pe296-304

Lawson JS, Glenn WK. Evidence for a causal role by human papillomaviruses in prostate cancer—a systematic review. Infect Agents Cancer 2020 Jul 14;15:41

Liu Y, Ang Q, Wu H, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009–2019. Virol J 2020 Jul 13;17:104

Luisi ML. From bad to worse: the representation of the HPV vaccine Facebook. Vaccine 2020 (published online May 13)

Lukacs A, Mate Z, Farkas N, et al. The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis. BMC Public Health 2020 May 28;20(691)

Mahumud RA, Alam K, Dunn J, et al. The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia. PLOS One 2019 Oct 9;14(10):e0223658

Mahumud RA, Alam K, Keramat SA, et al. Cost-effectiveness evaluations of the 9-valent human papillomavirus (HPV) vaccine: evidence from a systematic review. PLoS One 2020 (published online Jun 2)

Markowitz LE, Naleway AL, Klein NP, et al. Human papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses. J Infect Dis 2019 (published online Nov 30)

Meites E, Winer R, Newcomb ME, et al. Vaccine effectiveness on DNA prevalence of human papillomavirus infection in anal and oral specimens from men who have sex with men—United States, 2016–2018. J Infect Dis 2020 (published online Jun 6)

Melief CJM, Welters MJP, Vergote I, et al. Strong vaccine responses during chemotherapy are associated with prolonged cancer survival. Sci Trans Med 2020 Mar 18;12(535):eaaz8235

Mendez-Martinez R, Maldonado-Frias S, Vazquez-Vega S, et al. High prevalent human papillomavirus infections of the oral cavity of asymptomatic HIV-positive men. BMC Infect Dis 2020 Jan 10;20:27

Nguyen-Huu NH, Thilly N, Derrough T, et al. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. Vaccine 2019 (published online Dec 10)

Patel P, Bush T, Conley L, et al. Prevalence, incidence, and clearance of human papillomavirus types covered by current vaccines in men with human immunodeficiency virus in the SUN study. J Infect Dis 2019 (published online Sep 19)

Perkins RB, Legler A, Jansen E, et al. Improving HPV vaccination rates: a stepped-wedge randomized trial. Pediatrics 2020 Jul;146(1):e20192737

Phillips A, Hickie M, Totterdell J, et al. Adverse events following HPV vaccination: 11 years of surveillance in Australia. Vaccine 2020 (published online Jul 22)

Racey CS, Albert A, Donken R, et al. Cervical intraepithelial neoplasia rates in British Columbia women: a population level data linkage evaluation of the school-based HPV immunization program. J Infect Dis 2019 (published online Aug 23)

Reiter PL, Bustamante G, McRee A-L. HPV vaccine coverage and acceptability among a national sample of sexual minority women ages 18-45. Vaccine 2020 Jul 6;38(32):4956-63

Reuschenbach M, Mihm S, Wolle R, et al. Burden of HPV related anogenital diseases in young women in Germany—an analysis of German statutory health insurance claims data from 2012 to 2017. BMC Infect Dis 2020 (published online Apr 22)

Saadeh K, Park I, Gargano JW, et al. Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States. Vaccine 2019 (published online Oct 11)

Saslow D, Andrews KS, Manassaram-Baptiste D, et al. Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation. CA Cancer J Clin 2020 (published online Jul 8)

Sastre-Canton M, Perez-Vilar S, Vilata-Corell JJ, et al. Prevalence of oral human papillomavirus infection among university students in Valencia, Spain. Vaccine 2019 (published online Sep 9)

Schmuhl NB, Mooney KE, Zhang X, et al. No association between HPV vaccination and infertility in U.S. Females 18-33 years old. Vaccine 2020 (published online Apr 3)

Shilling H, Murray G, Brotherton JML, et al. Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening. Vaccine 2019 (published online Nov 22)

Shimabukuro TT, Su JR, Marquez PL, et al. Safety of the 9-valent human papillomavirus vaccine. Pediatrics 2019 (published online Nov 18)

Sonawane K, Nyitray AG, Nemutlu GS, et al. Prevalence of human papillomavirus infection by number of vaccine doses among US women. (Research letter) JAMA Netw Open 2019 (published online Dec 27)

Sonawane K, Zhu Y, Montealegre JR, et al. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey. Lancet Public Health 2020 (published online Jul 21)

Urbute A, Thomsen LT, Belmonte F, et al. The role of body mass index in incidence and persistence of cervical human papillomavirus infection. Ann Epidemiol 2020 (published online Jul 22)

Usyk M, Zolnik C, Castle PE, et al. Cervicovaginal microbiome and natural history of HPV in a longitudinal study. PLoS Pathog 2020 (published online Mar 26)

Vanska S, Luostarinen T, Baussano I, et al. Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied. J Infect Dis 2020 (published online Mar 11)

Vanska S, Luostarinen T, Lagheden C, et al. The age-specific cervical cancer incidence differs between human papillomavirus types: implications for predicting the impact of elimination programs. Am J Epidemiol 2020 (published online Jul 8)

Widdice LE, Bernstein DI, Franco EL, et al. Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction. Vaccine 2019 (published online Sep 30)

Wiener RC, Findley PA, Shen C, et al. Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015. Vaccine 2020 (published online Jun 19)

Winer RL, Lin J, Tiro JA, et al. Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial. JAMA Netw Open 2019 Nov 6;2(11):e1914729

Wiyeh AB, Cooper S, Jaca A, et al. Social media and HPV vaccination: unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa. Vaccine 2019 (published online Sep 11)

Woestenberg PJ, Morel AE, Bogaards JA, et al. Partial protective effect of bivalent HPV16/18 vaccination against anogenital warts in a large cohort of Dutch primary care patients. Clin Infect Dis 2020 (published online May 17)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»